Skip to content
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
January 10, 2025
Read More email
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-cell Therapy Produced from LineaDNA
December 18, 2024
Read More email
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
September 17, 2024
Read More email
Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
September 16, 2024
Read More email
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit
July 29, 2024
Read More email
Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA’s Linea DNA™ for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML
May 13, 2024
Read More email
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
April 25, 2024
Read More email
Applied DNA Announces Joint Development Agreement to Integrate Linea™ IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
December 14, 2023
Read More email
APDN Announces Receipt of Linea™ DNA Follow-On Order for Cancer Diagnostic Application
November 28, 2023
Read More email
Applied DNA Extends Application of Linea™ IVT Platform to saRNA (self-amplifying mRNA)
November 16, 2023
Read More email
APDN Announces Receipt of Largest Single Purchase Order for LinearDNA™ To-Date
October 10, 2022
Read More email
LinearDNA™ Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP)
August 10, 2022
Read More email
The Future of RNA Therapies Produced with LinearDNA™ IVT Templates
July 27, 2022
Read More email
APDN Launches Initiatives to Expand Awareness of LinearDNA™ Platform as an Alternative to Plasmid DNA for Therapeutic Applications, Revamps LineaRx Website
June 29, 2022
Read More email
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
June 7, 2022
Read More email
Spindle Biotech Research Collaboration on mRNA Production System
March 14, 2022
Read More email
Beefing Up Cancer Treatments, With A Vaccine In Sight
February 18, 2022
Read More email
LineaRx Receives Repeat Orders for LinearDNA
November 15, 2021
Read More email
Research Publication Demonstrates Utility of APDN’s LinearDNA™ in Non-Viral CAR T Manufacturing
November 9, 2021
Read More email
APDN, Evvivax Announce LinearDNA™ Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines
May 6, 2021
Read More email
Applied DNA and Evvivax Initiate Phase I of Clinical Trial to Evaluate LinearDNA™ COVID-19 Vaccine Candidate for Feline Veterinary Market
March 2, 2021
Read More email
APDN Develops Linear DNA Veterinary COVID-19 Vaccine
February 2, 2021
Read More email
APDN Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications
November 2, 2020
Read More email
APDN Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates
June 9, 2020
Read More email
APDN Provides Update on Linear-DNA COVID-19 Vaccine Candidates Development Program
June 8, 2020
Read More email
APDN to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27
May 21, 2020
Read More email
APDN and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
May 4, 2020
Read More email
Italian Biotech Startup Racing To Develop A Coronavirus Vaccine
April 21, 2020
Read More email
APDN High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital
April 21, 2020
Read More email
LI Biotech Speeds COVID-19 Vaccine Candidates To Italy
April 15, 2020
Read More email
APDN Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing
April 15, 2020
Read More email
APDN to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5
April 14, 2020
Read More email
APDN Ships LinearDNA™ to Another Development Customer
March 26, 2020
Read More email
APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer
March 20, 2020
Read More email
APDN Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection
March 19, 2020
Read More email
APDN COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models
March 18, 2020
Read More email
Stony Brook firm working on coronavirus vaccine
March 3, 2020
Read More email
Applied DNA, Takis Biotech design four Covid-19 vaccine candidates
March 3, 2020
Read More email
Applied DNA Speeds Coronavirus Vaccines Toward Tests
March 2, 2020
Read More email
APDN Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
March 2, 2020
Read More email
Applied DNA To Speed Up Coronavirus Countermeasures
February 13, 2020
Read More email
Applied DNA, Takis Biotech partner on coronavirus vaccine
February 11, 2020
Read More email
LineaRx and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV
February 7, 2020
Read More email
LineaRx, Inc. Signs Licensing Agreement with LifeSensors
January 13, 2020
Read More email
APDN to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020
January 10, 2020
Read More email
LineaRx signs agreement with TYME Technologies
November 29, 2019
Read More email
LineaRx Signs Agreement with TYME Technologies for Functional ICTC Assay Services in Pancreatic Cancer Trial
November 26, 2019
Read More email
APDN Reports 14 Development Customers for its Linear DNA Manufacturing Platform
November 25, 2019
Read More email
iCTC Platform Shows Superior Correlation over PSA as a Biomarker
October 1, 2019
Read More email
Linear DNA Combo Shows Punch In Cancer Fight
September 20, 2019
Read More email
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
September 19, 2019
Read More email
For Applied DNA, New Blood — And A Shot In The Arm
August 14, 2019
Read More email
Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx
August 12, 2019
Read More email
LineaRx Acquires Cancer Cell Assets and Intellectual Property of Vitatex
August 9, 2019
Read More email
LineaRx Acquires Assets and Intellectual Property of Vitatex
August 8, 2019
Read More email
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1, 2019
Read More email
LineaRx to Support Therapy Development for Neurodegenerative Diseases
June 26, 2019
Read More email
LineaRx Anticipates Expansion in Diagnostics Market
May 21, 2019
Read More email
LineaRx Achieves Higher Expression and Survival Rates in Human T Cells
April 29, 2019
Read More email
Linear DNA Crosses the Line between Tags and Therapeutics
April 9, 2019
Read More email
LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform
April 8, 2019
Read More email
LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1, 2019
Read More email
LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4, 2018
Read More email
LineaRx Provides Cost and Quality Advantages to Technogenetics
November 7, 2018
Read More email
At LineaRX, Putting The Horsepower Behind The CAR T
October 17, 2018
Read More email
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
October 16, 2018
Read More email
LineaRx Licenses CAR T Drug Candidate, Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16, 2018
Read More email
LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1, 2018
Read More email
LineaRx to Collaborate with Italian Companies Takis and Evvivax on Cancer Vaccines
September 20, 2018
Read More email
LineaRx Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20, 2018
Read More email
With New Spinoff, Biotech Goes All-In On DNA Sales
September 19, 2018
Read More email
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18, 2018
Read More email
APDN Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit
August 27, 2018
Read More email
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
